HealthLeaders Media December 5, 2018
John Commins

There’s a lot of talk about the potential for personalized medicine to lower drug costs.

Genetic testing has been around for a few years, and it’s being used to customize drug regimens for patients by better understanding how patients metabolize drugs. But proponents of individualized medicine are urging patience.

Konstantinos Lazaridis, MD, associate director of the Mayo Clinic’s Center for Individualized Medicine in Rochester, Minnesota, says that genetic testing is readily available and relatively inexpensive, costing between $300 and $400 per patient, although it’s not yet covered by insurance.

“It provides information about how you metabolize more than 300 medications that are commonly used in practice,” Lazaridis says. “What we have not proven is whether this reduces...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Precision Medicine, Technology
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article